{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-006634","form_type":"8-K","ticker":"BTMD","cik":"0001819253","company_name":"biote Corp.","filed_at":"2024-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.674769+00:00","generated_at":"2026-06-07T00:37:29.782613+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"biote Corp appoints Robert Peterson as CFO, succeeding Samar Kamdar","bullets":["Robert Peterson named CFO effective Jan 8, 2024; base salary $425,000 plus bonus and equity awards.","Samar Kamdar transitions out as CFO, to remain through Feb 29, 2024 as advisor; transition unrelated to financial results.","Peterson previously CFO of Virbac Corp; brings 15 years health/wellness and public company experience.","Peterson receives initial RSUs valued at $177,000 and 400,000 stock options under 2022 Equity Incentive Plan."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-006634","json":"https://secwatch.observer/filing/0001193125-24-006634.json","markdown":"https://secwatch.observer/filing/0001193125-24-006634.md","text":"https://secwatch.observer/filing/0001193125-24-006634.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819253/000119312524006634/0001193125-24-006634-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819253/000119312524006634/d715175d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T00:37:29.782613+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1328296d8f","claim":"Samar Kamdar changed role as Chief Financial Officer at biote Corp..","evidence_excerpt":"Samar Kamdar, the Company’s current Chief Financial Officer, will transition out of his role, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819253/000119312524006634/0001193125-24-006634-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will transition out of his role"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"a61b4d9594","claim":"Robert Peterson was appointed as Chief Financial Officer at biote Corp..","evidence_excerpt":"On January 8, 2024, biote Corp. (the “Company”) appointed Robert Peterson as Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819253/000119312524006634/0001193125-24-006634-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}